Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Items 701–800 of 1,000
Witkin, J. M., Ping, X., Cerne, R., Mouser, C., Jin, X., Hobbs, J., Tiruveedhula, V. V. N. P. B., Li, G., Jahan, R., Rashid, F., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146356 · Cited by 10
McCusker, P., Mian, M. Y., Li, G., Olp, M. D., Tiruveedhula, V. V. N. P. B., Rashid, F., Golani, L. K., Verma, R. S., Smith, B. C., Cook, J. M., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007826 · Cited by 10
Li, D., Chen, S., Chang, Y., & Yen, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030851 · Cited by 10
Inoue, M., Harada, K., Nakamura, J., & Matsuoka, H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.046 · Cited by 10
Benzodiazepine receptor agonists and insomnia: Is subtype selectivity lost in translation?
Ebert, B., & Wafford, K. A. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.11.008 · Cited by 10
Self-citationHollands, E. C., Dale, T., Baxter, A. W., Meadows, H. J., Powell, A. J., Clare, J. J., & Trezise, D. J. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109335675 · Cited by 10
GABAA Receptor α1 Subunit (Gabra1) Knockout Mice: Review and New Results
Ye, G.-L., Baker, K. B., Mason, S. M., Zhang, W., Kirkpatrick, L., Lanthorn, T. H., & Savelieva, K. V. (2009) · Neuromethods · doi:10.1007/978-1-60761-474-6_4 · Cited by 10
Use of a Novel Mouse Genotype to Model Acute Benzodiazepine Withdrawal
Metten, P., Buck, K. J., Merrill, C. M., Roberts, A. J., Yu, C.-H., & Crabbe, J. C. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9094-3 · Cited by 10
Rinaldi, D., Boutrel, B., Adrien, J., Venault, P., & Chapouthier, G. (2000) · Behavior Genetics · doi:10.1023/a:1026593232385 · Cited by 10
The 5′‐flanking region of the rat GABAA receptor α2‐subunit gene (Gabra2)
Fuchs, K., & Čelepirović, N. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01098.x · Cited by 10
The role of GABAA receptors in hippocampus-dependent cognitive functions
Nagarajan, R., Lyu, J., George, J. C., Rudolph, U., & Engin, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106659 · Cited by 9
Cerne, R., Smith, J. L., Chrzanowska, A., & LIPPA, A. S. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173895 · Cited by 9
Pharmacokinetics of clobazam oral soluble film
Heller, A. H., Wargacki, S., Jung, C., Buan, C., Wyatt, D. J., & Schobel, A. M. (2018) · Epilepsia · doi:10.1111/epi.14581 · Cited by 9
Reeves-Darby, J. A., Berro, L. F., Platt, D. M., Rüedi‐Bettschen, D., Shaffery, J. P., & Rowlett, J. K. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06450-3 · Cited by 9
Biological Modeling in the Discovery and Validation of Cognitive Dysfunctions Biomarkers
Iris, F. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_19 · Cited by 9
Raud, S., Reimets, R., Loomets, M., Sütt, S., Altpere, A., Visnapuu, T., Innos, J., Luuk, H., Plaas, M., Volke, V., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.019 · Cited by 10
Guillén-Ruiz, G., Bernal-Morales, B., Contreras, C. M., Cueto-Escobedo, J., & Rodríguez-Landa, J. F. (2016) · American Journal of Psychiatry and Neuroscience · doi:10.11648/j.ajpn.20160402.11 · Cited by 9
Contribution of the α5 GABAA receptor to the discriminative stimulus effects of propofol in rat
Wang, B., Lv, K., Liu, H., Su, Y., Wang, H., Wang, S., Bao, S., Zhou, W., & Lian, Q. (2018) · Neuroreport · doi:10.1097/wnr.0000000000000959 · Cited by 9
Diazepam and ethanol differently modulate neuronal activity in organotypic cortical cultures
Kreuzer, M., García, P. S., Brucklacher-Waldert, V., Claassen, R., Schneider, G. H., Antkowiak, B., & Drexler, B. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0540-6 · Cited by 9
Etemad, L., Farkhari, H., Alavi, M. S., & Roohbakhsh, A. (2020) · Drug Research · doi:10.1055/a-1206-6757 · Cited by 9
Hormones and Steroids as Neurotransmitters
Marwein, S., Biswal, S., & Acharya, P. C. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_14 · Cited by 9
Kaja, S., Payne, A. J., Nielsen, E. Ø., Thompson, C. L., van den Maagdenberg, A. M. J. M., Koulen, P., & Snutch, T. P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.044 · Cited by 9
Kumar, M., González, L. A., & Dillon, G. H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.007 · Cited by 9
Mitchell, C. P., Leszczuk, M., & Flaherty, C. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.004 · Cited by 9
Anxiolytic-like action of diazepam: mediated by GABAA receptors containing the α2-subunit
Crestani, F., Möhler, H., & Rudolph, U. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01772-7 · Cited by 9
Han, D., Försterling, F. H., Li, X., Deschamps, J. R., Parrish, D. A., Cao, H., Rallapalli, S., Clayton, T., Teng, Y., Majumder, S., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.072 · Cited by 9
Han, D., Försterling, F. H., Li, X., Deschamps, J. R., Cao, H., & Cook, J. M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.018 · Cited by 9
Javelot, H. (2015) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2015.09.001 · Cited by 9
Mechanisms of Antiepileptic Drug Action
Walker, M. C., Surges, R., & Fisher, A. (2009) · Wiley eBooks · doi:10.1002/9781118936979.ch6 · Cited by 9
Vidhan, J., Kumari, A., Singh, A., Gupta, R., Dhawan, J., & Kaur, J. (2018) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_8_18 · Cited by 9
Abecarnil and palatability: Taste reactivity in normal ingestion in male rats
COOPER, S., & RIDLEY, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.014 · Cited by 9
Low dose X-irradiation mitigates diazepam induced depression in rat brain
Kaur, A., Singla, N., & Dhawan, D. K. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.06.004 · Cited by 9
Synthesis and Antimicrobial Activity of New Isoxazolyl Benzo[1, 4] diazepine‐5‐one Derivatives
Ponduri, R., Kumar, P., & Vadali, L. R. (2018) · ChemistrySelect · doi:10.1002/slct.201802371 · Cited by 9
Propofol-benzodiazepine interactions: insights from a “bench to bedside” approach
Orser, B. A., & Miller, D. R. (2001) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03028303 · Cited by 9
June, H. L., & Eiler, W. J. A. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn036 · Cited by 9
Functional characterization of
Baethge, D.-B. K., Olbertz, J.-H., der Mathematisch-Naturwissenschaftlichen, D., & Hecht, S. (2014) · Cited by 9
Lewter, L. A., Woodhouse, K. L., Tiruveedhula, V. V. N. P. B., Cook, J. M., & Li, J. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002070 · Cited by 8
Roy, M. S., Sarkar, B. K., & Kundu, S. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33929 · Cited by 8
Qomi, H. R., Habibi, A., & Shahcheragh, S. M. (2016) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2016.11.028 · Cited by 8
Schlussman, S. D., Buonora, M. J., Brownstein, A. J., Zhang, Y., Ho, A., & Kreek, M. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.040 · Cited by 8
Tsai, J., Yang, P., Lin, H.-H., Cheng, K., Yang, Y., Wu, M., & Chen, C. (2013) · SLEEP · doi:10.5665/sleep.2372 · Cited by 8
Designer Benzodiazepines’ Activity on Opioid Receptors: A Docking Study
Catalani, V., Botha, M. J., Corkery, J., Guirguis, A., Vento, A. E., & Schifano, F. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220510153319 · Cited by 8
Andres‐Mach, M., Haratym-Maj, A., Zagaja, M. P., & Łuszczki, J. J. (2014) · Pharmacology · doi:10.1159/000360640 · Cited by 8
Milanos, S., Kuenzel, K., Gilbert, D. F., Janzen, D., Sasi, M., Buettner, A., Frimurer, T. M., & Villmann, C. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0262 · Cited by 8
Toolika, E., Ravi, M., Narayana Prakash, B., Shetty, S. K., Ravishankar, B., & Savitha, H. (2015) · The Journal of Phytopharmacology · doi:10.31254/phyto.2015.4304 · Cited by 8
If Only They Could Talk: Genetic Mouse Models for Psychiatric Disorders
Humby, T., & Wilkinson, L. S. (2006) · Contemporary clinical neuroscience · doi:10.1007/978-1-59745-058-4_4 · Cited by 8
CNS Drugs III: Psychotherapeutics
Marsden, C. A., & Stanford, S. C. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1923 · Cited by 8
Giving drugs to knockout mice: can they do that?
Chapman, P. F. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02158-6 · Cited by 8
Rudolph, U. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.33 · Cited by 8
α-Subunit selective modulators of GABAAreceptor function as CNS therapeutics
Hamilton, N. M., & Cooke, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.10.1491 · Cited by 8
Nelson, T. S., Holstein, S. E., Baird, J.-P., & Pittman, D. W. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.040 · Cited by 7
Reintroduction of quazepam: an update on comparative hypnotic and adverse effects
Moniri, N. H. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000277 · Cited by 7
Ren, Y., Xie, R., Marshall, S. F., Li, L., Zhou, T., & Lu, W. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1918-8 · Cited by 7
Hintermann, S., Hurth, K., Nozulak, J., Tintelnot‐Blomley, M., Aichholz, R., Blanz, J., Kaupmann, K., & Mosbacher, J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.107 · Cited by 7
Absorption, excretion, and metabolism of a potential GABA-Aα2/3receptor modulator in rats
Guo, J. P., Davis, P. C., Gu, C., & Grimm, S. W. (2011) · Xenobiotica · doi:10.3109/00498254.2010.545453 · Cited by 7
Clobazam for patients with Lennox–Gastaut syndrome and epilepsy
Eddeine, H. S., & Ng, Y. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.14 · Cited by 7
Analysis of Differential Efficacy and Affinity of GABAA(α1/α2) Selective Modulators
Ain, Q. U., Owen, R. M., Omoto, K., Torella, R., Bulusu, K. C., Pryde, D. C., Glen, R. C., Fuchs, J. E., & Bender, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00813 · Cited by 7
Söderhielm, P. C., Balle, T., Bak-Nyhus, S., Zhang, M., Hansen, K. M., Ahring, P. K., & Jensen, A. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.019 · Cited by 7
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands
Pandey, K. P., Khan, M. Z. A., Golani, L. K., Mondal, P., Mian, M. Y., Rashid, F., Tiruveedhula, V. V. N. P. B., Knutson, D. E., Sharmin, D., Ahmed, T., et al. (2020) · ARKIVOC · doi:10.24820/ark.5550190.p011.398 · Cited by 7
Attaining in vivo selectivity of positive modulation of α3βγ2 GABAA receptors in rats: A hard task!
Batinić, B., Stanković, T., Stephen, M. R., Kodali, R., Tiruveedhula, V. V. N. P. B., Li, G., Scholze, P., Marković, B. D., Obradović, A. L., Ernst, M. C., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.05.014 · Cited by 7
McDonald, L. M., Sheppard, W. F. A., Staveley, S. M., Sohal, B., Tattersall, F. D., & Hutson, P. H. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.009 · Cited by 7
New and Emerging Antiepileptic Drugs
Witkin, J. M., Golani, L. K., & Smith, J. L. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc099.pub3 · Cited by 7
Evaluating Remimazolam for Procedural Sedation
Monanian, G., Yonel, B., Rupert, D. D., Razak, A., DeLemos, M., & Bergese, S. D. (2025) · Current Neuropharmacology · doi:10.2174/011570159x367968250117034551 · Cited by 6
Anxiolytic-induced attenuation of thigmotaxis in the Elevated Minus Maze
Pickles, A. R., & Hendrie, C. A. (2013) · Behavioural Processes · doi:10.1016/j.beproc.2013.04.006 · Cited by 6
Hamilton, K. E., Shelton, C. M., Wheless, J. W., & Phelps, S. J. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.4.320 · Cited by 6
Warlick, H., Leon, L., Patel, R., Filoramo, S., Knipe, R., Joubran, E., Levy, A., Nguyen, H., & Rey, J. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08110-9 · Cited by 6
Liu, M., Wang, X., Zhang, D., Zhang, D., Pan, C., & 刘会臣 (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123723 · Cited by 6
Georgopoulos, P., Petrides, T., Kostopoulos, G., & Papatheodoropoulos, C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.017 · Cited by 7
Hopkins, S. C., Nofsinger, J. B., Allen, M. S., Koch, P., & Varney, M. A. (2009) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.641 · Cited by 6
Rinaldi, D., Larrigaldie, V., Chapouthier, G., & Martin, B. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00293-5 · Cited by 6
Joksimovic, S. M., Varagić, Z., Kovačević, J., Linn, M., Milić, M., Rallapalli, S., Stamenić, T. T., Sieghart, W., Cook, J. M., & Savić, M. M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3143-4 · Cited by 6
New Pharmacological Treatment Approaches for Anxiety Disorders
Ströhle, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_18 · Cited by 6
Pharmacology of Intravenous Anesthetics
García, P. S., Whalin, M. K., & Sebel, P. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00010-7 · Cited by 6
GABAA Receptor Subtypes: Memory Function and Neurological Disorders
Fritschy, J., Crestani, F., Rudolph, U., & Möhler, H. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0039-1_14 · Cited by 6
Development of non-sedating benzodiazepines with in vivo antischistosomal activity
Mian, M. Y., Sharmin, D., Mondal, P., Belayet, J. B., Hossain, M. M., McCusker, P., Ryan, K. T., Fedorov, A. Y., Green, H. A., Ericksen, S. S., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00369-24 · Cited by 5
Discovery of Novel Antiepileptic Agents Targeting the α1β2γ2 GABAA Receptor
Gao, Y., Noraddin, A., Li, X., Zhu, C., Zhang, Y., Jin, Y., Zhang, M., Yu, Y., Wang, X., Wang, K., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01770 · Cited by 5
Zolpidem withdrawal seizure in an Iranian young woman: A case presentation.
Hadinezhad, P., & Hosseini, S. H. (2021) · PubMed Central · doi:10.22088/cjim.12.0.376 · Cited by 5
Sebihi, S., Monperrus, M., Coste, P., Huchet, E., Lingrand, M., Glise, S., Bouchard, C., Ortiz‐Zarragoitia, M., & Bolliet, V. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106627 · Cited by 5
Payghan, P. V., Roy, S. N., Bhattacharyya, D., & Ghoshal, N. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1508367 · Cited by 5
Cao, J.-W., Guan, W., Yu, Y., & Fu, Y. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.008 · Cited by 5
Fast Inhibitory Transmission of Pain in the Spinal Cord
Zeilhofer, H. U., Witschi, R., & Johansson, T. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0226-9_3 · Cited by 5
Bigued, Taïwé, G. S., Njapdounké, J. S. K., Ngaibi, J., Nguezeye, Y., Sidiki, N., & Bum, E. N. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.14.3.0078 · Cited by 5
Therapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome
van der Lei, M. B., & Kooy, R. F. (2022) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.2008168 · Cited by 5
High-Dose Zolpidem Withdrawal Seizure in a Patient With Spinocerebellar Ataxia
Chang, C., & Wang, W. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.10l01114 · Cited by 5
GABA and Glutamate Receptor Ligands and their Therapeutic Potential in CNS Disorders
Madsen, U., Bräuner‐Osborne, H., Greenwood, J. R., Johansen, T. N., Krogsgaard‐Larsen, P., Liljefors, T., Nielsen, M., & Frølund, B. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse019 · Cited by 5
McMahon, L. R., & France, C. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0028-1 · Cited by 5
GABACρ1Subunits Form Functional Receptors But Not Functional Synapses in Hippocampal Neurons
Cheng, Q., Burkat, P. M., Kulli, J. C., & Yang, J. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.5.2605 · Cited by 5
Modulators of the GABAA receptor: Novel therapeutic prospects
Thomsen, C., & Ebert, B. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch18 · Cited by 5
Serrats, J., Vadodaria, K. C., Brubaker, W., Barker‐Haliski, M. L., White, H. S., Evrard, A., Roucard, C., Taylor, E. M., Vanover, K. E., Cunningham, S., et al. (2025) · Epilepsia · doi:10.1111/epi.18340 · Cited by 4
Bauquier, S. H. (2024) · Wiley eBooks · doi:10.1002/9781118975169.ch6 · Cited by 4
Effects of zuranolone on next-day simulated driving in healthy adults
Dunbar, J., Morelli, G., Jain, R., Vaudreuil, C., Nandy, I. M., Ona, V. O., Moseley, M. K., Levin, S. N., & Kay, G. G. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06687-6 · Cited by 4
Rowlett, J. K., Kehne, J. H., Sprenger, K., & Maynard, G. D. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2093-3 · Cited by 4
Wang, X., Song, Z., Huang, D., Gao, H., Wang, Q., & Wang, Z. P. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15027340 · Cited by 4
Tuk, B. (2016) · F1000Research · doi:10.12688/f1000research.8774.2 · Cited by 4
Safaei‐Ghomi, J., Paymard‐Samani, S., & Shahbazi‐Alavi, H. (2018) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.201700349 · Cited by 4
Impact of Artisanal Gold Mining on Wetland Health in Buhweju District, Southwestern Uganda
Nuwagira, U., Mubiru, D., Yasin, I., & Nasasira, P. (2023) · East African Journal of Environment and Natural Resources · doi:10.37284/eajenr.6.1.1420 · Cited by 4
Study of active site and SAR of some benzodiazepines
Thakur, M., Ojha, L. K., Thakur, A., & Solanki, B. K. (2010) · Journal of Computational Biology and Bioinformatics Research · doi:10.5897/jcbbr.9000018 · Cited by 4
Jain, A., Rishu, S., & Nidhi, G. (2010) · International Journal of Pharmacy and Life Sciences · Cited by 4
GABAa receptori - molekulski supstrat za razvoj novih anksiolitika
Obradovic, D. I., Savić, M. M., Ugrešić, N. D., & Bokonjić, D. (2003) · Vojnosanitetski pregled · doi:10.2298/vsp0303345o · Cited by 4
4-Phenyl-1H-1,5-benzodiazepin-2(3H)-one
Akkurt, M., Kennedy, A. R., Younes, S. H. H., Mohamed, S. K., & Abdelhamid, A. A. (2012) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s160053681204651x · Cited by 4
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.